HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadafumi Terada Selected Research

TPY-835

9/2005A novel cinnamic acid derivative that inhibits Cdc25 dual-specificity phosphatase activity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadafumi Terada Research Topics

Disease

2Hepatocellular Carcinoma (Hepatoma)
08/2007 - 12/2006
2Neoplasms (Cancer)
09/2005 - 06/2005
1Lung Neoplasms (Lung Cancer)
09/2005
1Retinoblastoma (Glioblastoma, Retinal)
09/2005

Drug/Important Bio-Agent (IBA)

2Fluorouracil (Carac)FDA LinkGeneric
08/2007 - 12/2006
1Dihydrouracil Dehydrogenase (NADP) (Dihydropyrimidine Dehydrogenase)IBA
08/2007
1Interferon alpha-beta Receptor (Receptor, Interferon alpha beta)IBA
12/2006
1InterferonsIBA
12/2006
1Interferon-alpha (Interferon Alfa)IBA
12/2006
1Retinoblastoma ProteinIBA
09/2005
1Antineoplastic Agents (Antineoplastics)IBA
09/2005
1TPY-835IBA
09/2005
1Dactinomycin (Actinomycin)FDA LinkGeneric
06/2005
1Etoposide (VP 16)FDA LinkGeneric
06/2005
1Cisplatin (Platino)FDA LinkGeneric
06/2005
1Messenger RNA (mRNA)IBA
06/2005
1Vincristine (Oncovin)FDA LinkGeneric
06/2005
1DNA (Deoxyribonucleic Acid)IBA
06/2005
1Doxorubicin (Adriamycin)FDA LinkGeneric
06/2005

Therapy/Procedure

1Therapeutics
12/2006
1Aftercare (After-Treatment)
09/2005